Yes and I like this:
"The JV is working to determine how best to phase the development of the large resource base. We are also consolidating our views on how the changes in industry pricing will impact the capital expenditure cost estimates of development including the economic field size."
In other words a phased development with significantly lower costs hence economic at lower oil prices.
H
- Forums
- ASX - By Stock
- FAR
- Cairn Half Yearly highlights
Cairn Half Yearly highlights, page-9
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FAR (ASX) to my watchlist
|
|||||
Last
49.5¢ |
Change
-0.010(1.98%) |
Mkt cap ! $45.74M |
Open | High | Low | Value | Volume |
50.5¢ | 50.5¢ | 49.5¢ | $26.98K | 54.03K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20223 | 49.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 611 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20223 | 0.495 |
1 | 2000 | 0.485 |
2 | 28930 | 0.480 |
2 | 70000 | 0.475 |
2 | 78150 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 611 | 1 |
0.510 | 59999 | 2 |
0.525 | 69690 | 1 |
0.530 | 30000 | 1 |
0.535 | 30000 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
FAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online